Expertise in
25
conditions

Dr. Carter T. Davis

Hematology Oncology
1514 Jefferson Highway, 
New Orleans, LA 
Accepting New Patients
Offers Telehealth
Expertise in
25
conditions
1514 Jefferson Highway, 
New Orleans, LA 

Overview

Carter Davis is a Hematologist Oncology provider practicing medicine in New Orleans, Louisiana.

Dr. Davis is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Davis is board certified in American Board Of Internal Medicine - Hematology/Oncology. He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 4 clinical trials. Dr. Davis is currently accepting new patients.

Specialties

Hematology Oncology

Board Certifications

American Board Of Internal Medicine - Hematology/Oncology

Hospital Affiliations

Ochsner Medical Center Acute
Ochsner Medical Center-Hancock
Slidell Memorial Hospital
Ochsner Medical Center-Kenner
Ochsner Medical Center - Baton Rouge

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

The Gayle and Tom Benson Cancer Center
1514 Jefferson Highway, New Orleans, LA 70121

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (>/= 65 Years of Age) With Chronic Lymphocytic Leukemia (CLL)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Drug, Biological, Other
Study Drugs: Ibrutinib, Obinutuzumab, Venetoclax
Study Phase: Phase 3
Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment With Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy
Solitary Plasmacytoma of Bone: Randomized Phase III Trial to Evaluate Treatment With Adjuvant Systemic Treatment and Zoledronic Acid Versus Zoledronic Acid After Definite Radiation Therapy
Enrollment Status: Terminated
Publish Date: June 30, 2026
Intervention Type: Drug
Study Drugs: Ixazomib, Lenalidomide, Dexamethasone, Zoledronic acid
Study Phase: Phase 3
A Randomized Phase II/III Trial of Novel Therapeutics Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
A Randomized Phase II/III Trial of Novel Therapeutics Versus Azacitidine in Newly Diagnosed Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS), Age 60 or Older LEAP: Less-Intense AML Platform Trial
Enrollment Status: Completed
Publish Date: January 16, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Azacitidine, Cytarabine, Decitabine, Midostaurin, Nivolumab
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

4 Total Publications

The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasm.
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasm.
Journal: Expert opinion on biological therapy
Published: December 25, 2025
Similar Doctors
Expertise in
16
conditions
Dr. Ashley D. Staton
Hematology Oncology
Expertise in
16
conditions
Dr. Ashley D. Staton
Hematology Oncology
Referral may be required
Before you request

Ochsner Medical Center - New Orleans

1514 Jefferson Hwy, 
New Orleans, LA 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ashley Staton is a Hematologist Oncology provider practicing medicine in New Orleans, Louisiana. Dr. Staton is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Staton is board certified in American Board Of Internal Medicine - Hematology/Oncology. Dr. Staton is currently accepting new patients.

Expertise in
16
conditions
Dr. Laura C. Chauvin
Hematology Oncology
Expertise in
16
conditions
Dr. Laura C. Chauvin
Hematology Oncology
Referral may be required
Before you request

Ochsner Health Center - Kenner

200 W Esplanade Ave, 
Kenner, LA 
 (8.7 miles away)
504-842-7690
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Laura Chauvin is a Hematologist Oncology provider practicing medicine in Kenner, Louisiana. Dr. Chauvin is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Monoclonal Gammopathy of Undetermined Significance (MGUS), Paget Disease of the Breast, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Chauvin is board certified in American Board Of Internal Medicine - Hematology/Oncology. Dr. Chauvin is currently accepting new patients.

Expertise in
13
conditions
Dr. Chris G. Theodossiou
Hematology Oncology
Expertise in
13
conditions
Dr. Chris G. Theodossiou
Hematology Oncology
Referral may be required
Before you request

St. Tammany Cancer Center - A Campus Of Ochsner Medical Center

900 Ochsner Blvd, 
Covington, LA 
 (33.8 miles away)
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Chris Theodossiou is a Hematologist Oncology provider practicing medicine in Covington, Louisiana. Dr. Theodossiou is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Bone Marrow Aspiration, and Endoscopy. Dr. Theodossiou is board certified in American Board Of Internal Medicine - Hematology/Oncology. Dr. Theodossiou is currently accepting new patients.

Frequently Asked Questions about Dr. Carter T. Davis

Is Dr. Carter T. Davis a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Carter T. Davis is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Carter T. Davis specialize in?

While Dr. Carter T. Davis is a Hematology Oncology, they have specific expertise in Multiple Myeloma, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Carter T. Davis participate in research or clinical trials?

Yes. Dr. Carter T. Davis has published 4 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Carter T. Davis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Carter T. Davis accept my insurance?

Dr. Carter T. Davis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Davis's expertise for a condition
ConditionClose
    View All 23 Advanced Conditions
    View All 50 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile